CONFIGLIDE, created in 2009 (United States), from 496 sister brands and 17477 competing brands. CONFIGLIDE is a brand of BRISTOL-MYERS SQUIBB COMPANY, listed on the stock exchange of New York. The sector of CONFIGLIDE is Drug Manufacturers.
Investment simulator :
Portfolio valuation
BRISTOL-MYERS SQUIBB COMPANY
(CONFIGLIDE)
over 5 years*
USD 40.61